Order MiniMed™ 780G System | Medtronic

MiniMed™ 780G insulin pump system

Product code:MMT-1894

  • MiniMed™ 780G System
  • MiniMed™ 780G System
  • MiniMed™ 780G System
  • MiniMed™ 780G System
  • MiniMed™ 780G System
  • MiniMed™ 780G System
  • MiniMed™ 780G System
  • MiniMed™ 780G System
  • MiniMed™ 780G System
  • MiniMed™ 780G System

Quantity: 1

Price varies
pending insurance

Covered by most insurance

Prescription required


Product Information

Designed for real life
The only system with meal detection technology* that automatically adjusts and corrects† sugar levels every 5 minutes§ to help prevent highs all day and night.


Features

  • Auto correction. Helps make up for carb counts that aren’t always exact or the occasional missed meal dose.*
  • No fingersticks in SmartGuard™ technology with the new Guardian™ 4 sensor.∑
  • Flexible glucose targets (100, 110, 120mg/dL). The only system that allows you to choose** from 3 glucose targets. When using the lowest glucose target of 100 mg/dL, the system safely treats to a lower target than other pumps, without increasing lows.4


Meal detection technology

What if you underestimate your carb count?
Before a meal*, enter estimated carb count into your pump.
If the system detects a meal, based on the rapid rise of your sugar levels, it automatically§ delivers stronger correction doses while sugar levels are rising, up to every 5 minutes, to help prevent highs.

What if you occasionally miss a meal dose?
Let’s say life happens and you forgot to give yourself a meal dose.
If you’re trending high, the system automatically delivers a correction dose to help bring you safely back in range.
The MiniMed™ 780G system is designed with SmartGuard™ technology, an advanced algorithm that uses current and past sugar level trends to anticipate, adjust, and correct insulin delivery.

What if your sugar levels are trending high?
The system automatically gives you more insulin.

What if your sugar levels are trending low?
The system automatically reduces the amount of insulin delivered.


MiniMed™ 780G system components

    Insulin pump
    Based on info received from the CGM every 5 minutes,§ the pump makes automatic adjustments and corrections to your insulin delivery.

    Continuous glucose monitor
    The Guardian™ 4 sensor & transmitter measure glucose levels every 5 minutes,§ sending info to the pump with no fingersticks when using SmartGuard™ technology.∑

    Infusion set
    The Medtronic Extended infusion set allows for continuous and discreet delivery of insulin through a thin, flexible tube and can be worn up to 7 days.

    Smartphone app
    Get notified of highs and lows with the MiniMed™ Mobile app. Care partners can download the CareLink™ app to stay in the know.


Getting started on the MiniMed™ 780G system
If you’re ready to upgrade,Sign in to see your system upgrade offers. After submitting your request, an agent will reach out to you and answer any questions you may have.

Is this your first Medtronic insulin pump? Fill out an interest form.

Smart devices sold separately. For a list of compatible devices, refer to user guide.
*Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
§ Refers to SmartGuard™ feature. Individual results may vary.
† Refers to auto correct, which provides bolus assistance. Can deliver all auto correction doses automatically without user interaction, feature can be turned on and off.
** Glucose targets should be chosen following a consultation with your healthcare provider.
Σ Fingersticks required in manual mode & to enter SmartGuard™. If symptoms don’t match alerts & readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard™.

References

  1. Adults, T1 and parents of children with T1 diabetes < 18 years were surveyed.
  2. Individual results may vary.
  3. dQ&A US Diabetes Patient Panel Report; Customer Overall Satisfaction, n=146; Q4 2023: P.52 (November 2023).
  4. Matejko B. et al, Diabetes Care. 2022; https://doi.org/10.2337/dc22-0470


‡CGM4U Program Terms & Conditions
MiniMed™ 780G System Offer
Terms & Conditions
  • Offer is available until April 27, 2024 to existing Medtronic customers upgrading to or purchasing the MiniMed™ 780G system with commercial insurance.
  • The MiniMed™ 780G System Program is for CGM upgrades only. CGM transmitters and sensors are included with this transaction.
  • Customers must have an out-of-warranty transmitter (Medtronic or competitor) or no CGM to participate in the MiniMed™ 780G System Program.
  • Customers will pay $100 out-of-pocket to purchase one (1) Medtronic Guardian™ 4 CGM transmitter and one (1) 5-pack of Guardian™ 4 sensors. A customer's insurance will not be billed for this initial order.
  • Customers will be able to receive up to two (2) boxes of Guardian™ 4 sensors at no cost if Medtronic Guardian™ Sensor 3 were purchased in the last 90 days.
  • Customers who do not purchase supplies from Medtronic should call Medtronic to participate in the program. Ongoing supplies should continue to be purchased through current supply provider (distributor).
  • Offer applies to a maximum of one (1) Guardian™ 4 transmitter per customer and cannot be used in conjunction with the CGM Pathway Program or Competitor CGM Pathway Program.
  • Customers who decide not to continue with the Medtronic Guardian™ 4 CGM have 60-days from date of purchase to initiate the refund process and Medtronic will refund the $100 out of pocket that was paid.
  • MiniMed™ CGM have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your Healthcare Provider regarding indications for use.
  • A valid prescription will be required to obtain a new CGM. Other restrictions may apply.
  • Customers should verify that their insurance provider will support transitioning to the new CGM, as it could affect ongoing coverage of their future CGM supplies.
  • This program is only available to customers whose payers bill transmitters and sensors separately. Customers whose payers utilize a monthly CGM supply allowance are excluded from this program.
  • Customers with commercial insurance residing in Massachusetts & Michigan and/or customers enrolled in any federal, state, or government-funded healthcare are excluded from this program.
  • Kaiser & Excellus health plans are excluded from this program.
  • Program terms and conditions are subject to change at any time and without notice.


CGM Pathway Offer
Terms & Conditions
  • The Continuous Glucose Monitor (CGM) Pathway Program is for CGM transmitter upgrades only. CGM supplies and consumables are not included, unless otherwise stated.
  • Customers must have a Medtronic in-warranty transmitter to participate in the CGM Pathway Program.
  • Customers transitioning from one Medtronic CGM system will not have any upfront out-of-pocket costs to Pathway to another Medtronic CGM transmitter.
  • Upon completion of the transaction, customers will receive one (1) transmitter that is the latest technology compatible with their current pump system.
  • The CGM Pathway Program does not extend the warranty period of the replaced product. The customer’s current warranty timeline will not change by obtaining a CGM transmitter through this program.
  • Offer applies to a maximum of one (1) transmitter per customer and cannot be used in conjunction with the MiniMed™ 780G System Program or Competitor CGM Pathway Program.
  • Customers who do not purchase supplies from Medtronic should call Medtronic to participate in the program. Ongoing supplies should continue to be purchased through current supply provider (distributor).
  • Certain labeling restrictions for MiniMed™ CGM may exclude certain populations, including age and type of diabetes. We recommend you consult your Healthcare Provider regarding indications for use.
  • A valid prescription will be required to obtain a new CGM. Other restrictions may apply.
  • Customers should verify that their insurance provider will support transitioning to the new CGM, as it could affect ongoing coverage of their future CGM supplies.
  • This program is available to customers whose payers bill transmitters and sensors separately. Customers whose payers utilize a monthly CGM supply allowance are excluded from this program.
  • Customers will be able to receive up to two (2) boxes of Guardian™ 4 sensors at no cost if Medtronic Guardian™ Sensor 3 were purchased in the last 90 days.
  • Special restrictions apply for customers with commercial insurance residing in Massachusetts & Michigan and/or customers enrolled in any federal, state, or government-funded healthcare. Refer to special circumstances’ terms & conditions.
  • Kaiser health plans are excluded from this program.
  • Program terms and conditions are subject to change at any time and without notice.

CGM Pathway Special Circumstances
Terms & Conditions
  • Special circumstances apply for customers with commercial insurance residing in Michigan & Massachusetts; and/or customers with federal, state, and government-funded healthcare.
  • Customers must return their old transmitter within 30 days. Customers who do not return their CGM will be charged $200.
  • Customers are not able to receive up to two (2) boxes of Guardian™ 4 sensors at no cost if Medtronic Guardian™ Sensor 3 were purchased in the last 90 days.
  • Customer agrees that the amount paid to Medtronic is commercially reasonable considering the approximate value of the exchanged CGM, the price of the new CGM, and the relationship between the parties.
  • As applicable, Customer agrees to fully and accurately report in submissions to federal healthcare programs all discounts provided by Medtronic and, upon request by the Secretary of the U.S. Department of Health and Human Services or state agency, make available information any information that Medtronic may provide concerning the discount.

Competitor CGM Pathway Offer
Terms & Conditions
  • The Competitor Continuous Glucose Monitor (CGM) Pathway Program is for Competitor CGM upgrades only. CGM transmitters and sensors are included with this transaction.
  • Customers must have an in-warranty transmitter to participate in the Competitor Continuous Glucose Monitor (CGM) Pathway Program.
  • Customers using disposable CGM systems like Freestyle Libre or Dexcom G7 are not eligible for the Competitor CGM Pathway Program.
  • Customers transitioning from a Competitor CGM will pay $100 out-of-pocket to purchase one (1) Medtronic CGM transmitter that is compatible with their current therapy regimen and one (1) 5-pack of sensors.
  • The Competitor CGM Pathway Program does not extend the warranty period of the replaced product. The customer’s current warranty timeline will not change by purchasing a CGM through this program.
  • Offer applies to a maximum of one (1) transmitter per customer and cannot be used in conjunction with the CGM Pathway Program or MiniMed™ 780G System Program.
  • Customers have 60-days from date of purchase to initiate the refund process and Medtronic will refund the $100 out of pocket that was paid.
  • This program is available to customers whose payers bill transmitters and sensors separately. Customers whose payers utilize a monthly CGM supply allowance are excluded from this program.
  • Certain labeling restrictions for MiniMed™ CGM may exclude certain populations, including age and type of diabetes. We recommend you consult your Healthcare Provider regarding indications for use.
  • Customers should verify that their insurance provider will support transitioning to the new CGM, as it could affect ongoing coverage of their future CGM supplies.
  • A valid prescription will be required to obtain a new CGM. Other restrictions may apply.
  • Special restrictions apply for customers with commercial insurance residing in Massachusetts & Michigan and/or customers enrolled in any federal, state, or government-funded healthcare. Refer to special circumstances terms & conditions.
  • Kaiser health plans are excluded from this program.
  • Program terms and conditions are subject to change at any time and without notice.

Competitor CGM Pathway Special Circumstances
Terms & Conditions
  • Special circumstances apply for customers with commercial insurance residing in Michigan & Massachusetts; and/or customers with federal, state, and government-funded healthcare.
  • Customers must return their old transmitter within 30 days. Customers who do not return their CGM will be charged $200.
  • Customer agrees that the amount paid to Medtronic is commercially reasonable considering the approximate value of the exchanged CGM, the price of the new CGM, and the relationship between the parties.
  • As applicable, Customer agrees to fully and accurately report in submissions to federal healthcare programs all discounts provided by Medtronic and, upon request by the Secretary of the U.S. Department of Health and Human Services or state agency, make available information any information that Medtronic may provide concerning the discount.


IMPORTANT SAFETY INFORMATION: MINIMED™ 780G SYSTEM WITH SMARTGUARD™ TECHNOLOGY WITH GUARDIAN™ 4 SENSOR

The MiniMed™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 780G system consists of the following devices: MiniMed™ 780G insulin pump, the Guardian™ 4 transmitter, the Guardian™ 4 sensor, One-press serter, the Accu-Chek™ Guide Link blood glucose meter, and the Accu-Chek™Guide test strips. The system requires a prescription from a healthcare professional.

The Guardian™ 4 sensor is intended for use with the MiniMed™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian™ 4 sensor is indicated for up to seven days of continuous use.

The Guardian™ 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ 4 sensor. The Guardian™ 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian™ 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.



WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.

WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library.